Search - tctmd.com

Displaying 681 - 700 of 1092

Sort: Relevancy | Date

Presentation TCT 2022

TCT 50: Impact of Cardiac Arrest and SCAI Classification on STEMI and NSTEMI Cardiogenic Shock

Presenter: Mohit Pahuja

September 17, 2022

Presentation TCT 2022

TCT 50: Impact of Cardiac Arrest and SCAI Classification on STEMI and NSTEMI Cardiogenic Shock

Presenter: Mohit Pahuja

September 17, 2022

Presentation TCT 2022

TCT 322: National Trends in TAVR and SAVR for Patients with Severe Isolated Aortic Stenosis

Presenter: Toishi Sharma

September 17, 2022

Presentation TCT 2022

TCT 23: Influence of the circadian clock on the pharmacodynamic effect of prasugrel in patients presenting with ST-segment elevation myocardial infarction – A COMPARE CRUSH subanalysis

Presenter: Rosanne Vogel

September 17, 2022

Presentation TCT 2022

TCT 215: Association between Renal Sympathetic Denervation and Arterial Stiffness: the ASORAS Study.

Presenter: Victor Zeijen

September 17, 2022

Presentation TCT 2022

TCT 59: Impact of prolonged dual antiplatelet therapy duration on bioresorbable scaffolds outcomes: five-year data from a prospective registry.

Presenter: Giulia Masiero

September 17, 2022

Presentation TCT 2022

TCT 22: Clopidogrel versus Aspirin in the Chronic Maintenance Period Following Percutaneous Coronary Intervention in Patients with Acute Coronary syndrome: Subgroup Analysis of the HOST-EXAM trial

Presenter: Jeehoon Kang

September 17, 2022

Presentation TCT 2022

TCT 214: Single Ablation Renal Denervation – The RADAR Study Experience with the Metavention iRF System

Presenter: Horst Sievert

September 17, 2022

Presentation TCT 2022

TCT 58: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final: 5 Year Clinical Outcomes

Presenter: Matthias Lutz

September 17, 2022

Presentation TCT 2022

TCT 212: Twenty-Four Month Results in Patients with Resistant Hypertension After Endovascular Ultrasound Renal Denervation in the RADIANCE-HTN TRIO Trial

Presenter: Roland Schmieder

September 17, 2022

Presentation TCT 2022

TCT 57: Everolimus-eluting Bioresorbable Vascular Scaffolds for Coronary Atherosclerosis Restoration Therapy: Insights on Long-term Intracoronary Imaging and Physiological Results of Bioresorption

Presenter: Gabriele Pesarini

September 17, 2022

Presentation TCT 2022

TCT 20: Relative benefit of double versus triple antithrombotic therapy in patients with atrial fibrillation randomized earlier versus later after index coronary event: Insights from the AUGUSTUS Trial

Presenter: Alexander Fanaroff

September 17, 2022

Presentation

TCT 211: Home Blood Pressure Response to Ultrasound Renal Denervation - a Patient-level Pooled Analysis of the RADIANCE-HTN SOLO and TRIO Randomised, Sham-controlled Trials

Presenter: Andrew Sharp

September 17, 2022

Presentation TCT 2022

TCT 56: Long-term outcomes after bioresorbable vascular scaffold implantation in patients with de-novo coronary artery disease.

Presenter: Marta Konopko

September 17, 2022

Presentation TCT 2022

TCT 19: Thrombin Generation and Endothelial Progenitor Cell Function in Patients with Acute Myocardial Infarction Treated with Prasugrel versus Ticagrelor

Presenter: Mark Kheifets

September 17, 2022

Presentation TCT 2022

TCT 213: Impact of Cardiac Neuromodulation Therapy (CNT) on Systolic Blood Pressure and Pulse Pressure in Hypertensive Patients Indicated for a Pacemaker: Results of a Crossover Study

Presenter: Daniel Burkhoff

September 17, 2022

Presentation TCT 2022

TCT 69: Impella use for fulminant myocarditis in cardiogenic shock: Analysis of the Japan Registry for Percutaneous Ventricular Assist Device (J-PVAD)

Presenter: Koichi Toda

September 17, 2022

Presentation TCT 2022

TCT 38: Impact of Smoking on Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention

Presenter: Marta Bujak

September 17, 2022

Presentation TCT 2022

TCT 210: Long-term blood pressure results after renal sympathetic denervation using endovascular ultrasound

Presenter: Karl Fengler

September 17, 2022

Presentation TCT 2022

TCT 65: Pulmonary Artery Catheter Use is Associated with Lower Mortality in Cardiogenic Shock, Especially among Patients with Heart Failure

Presenter: Navin Kapur

September 17, 2022

Advertisement

TCT 50: Impact of Cardiac Arrest and SCAI Classification on STEMI and NSTEMI Cardiogenic Shock

TCT 50: Impact of Cardiac Arrest and SCAI Classification on STEMI and NSTEMI Cardiogenic Shock

TCT 322: National Trends in TAVR and SAVR for Patients with Severe Isolated Aortic Stenosis

TCT 23: Influence of the circadian clock on the pharmacodynamic effect of prasugrel in patients presenting with ST-segment elevation myocardial infarction – A COMPARE CRUSH subanalysis

TCT 215: Association between Renal Sympathetic Denervation and Arterial Stiffness: the ASORAS Study.

TCT 59: Impact of prolonged dual antiplatelet therapy duration on bioresorbable scaffolds outcomes: five-year data from a prospective registry.

TCT 22: Clopidogrel versus Aspirin in the Chronic Maintenance Period Following Percutaneous Coronary Intervention in Patients with Acute Coronary syndrome: Subgroup Analysis of the HOST-EXAM trial

TCT 214: Single Ablation Renal Denervation – The RADAR Study Experience with the Metavention iRF System

TCT 58: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final: 5 Year Clinical Outcomes

TCT 212: Twenty-Four Month Results in Patients with Resistant Hypertension After Endovascular Ultrasound Renal Denervation in the RADIANCE-HTN TRIO Trial

TCT 57: Everolimus-eluting Bioresorbable Vascular Scaffolds for Coronary Atherosclerosis Restoration Therapy: Insights on Long-term Intracoronary Imaging and Physiological Results of Bioresorption

TCT 20: Relative benefit of double versus triple antithrombotic therapy in patients with atrial fibrillation randomized earlier versus later after index coronary event: Insights from the AUGUSTUS Trial

TCT 211: Home Blood Pressure Response to Ultrasound Renal Denervation - a Patient-level Pooled Analysis of the RADIANCE-HTN SOLO and TRIO Randomised, Sham-controlled Trials

TCT 56: Long-term outcomes after bioresorbable vascular scaffold implantation in patients with de-novo coronary artery disease.

TCT 19: Thrombin Generation and Endothelial Progenitor Cell Function in Patients with Acute Myocardial Infarction Treated with Prasugrel versus Ticagrelor

TCT 213: Impact of Cardiac Neuromodulation Therapy (CNT) on Systolic Blood Pressure and Pulse Pressure in Hypertensive Patients Indicated for a Pacemaker: Results of a Crossover Study

TCT 69: Impella use for fulminant myocarditis in cardiogenic shock: Analysis of the Japan Registry for Percutaneous Ventricular Assist Device (J-PVAD)

TCT 38: Impact of Smoking on Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention

TCT 210: Long-term blood pressure results after renal sympathetic denervation using endovascular ultrasound

TCT 65: Pulmonary Artery Catheter Use is Associated with Lower Mortality in Cardiogenic Shock, Especially among Patients with Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content